Preliminary experience using the transcatheter mitral valve leaflet repair procedure

Israel Medical Association Journal

Volumn 15, Issue 10, 2013, Pages 608-612

  Perl, Leor ^a   Vaturi, Moti ^a   Assali, Abid ^a   Shapira, Yaron ^a   Bruckheimer, Elchanan ^b   Ben Gal, Tuvia ^a   Vaknin Assa, Hana ^a   Sagie, Alik ^a   Kornowski, Ran ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Heart failure; Mitraclip ; Mitral regurgitation (MR); Trans septal puncture; Transcatheter mitral valve leaflet repair (TMLR)

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FLUOROSCOPY; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORBIDITY; MORTALITY; PROSPECTIVE STUDY; STRESS ULCER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; COHORT STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84887202911     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol 1999; 83 (6): 897-902.
2. Robbins JD, Maniar PB, Cotts W, et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 2003; 91 (3): 360-2.
3. Strauss RH, Stevenson LW, Dadourian BA, et al. Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation. Am J Cardiol 1987; 59 (8): 892-4.
4. Carpentier A. Cardiac valve surgery: the "French correction." J Torac Cardiovasc Surg 1983; 86: 323-37.
5. Fedak PW, McCarthy PM, Bonow RO. Evolving concepts and technologies in mitral valve repair. Circulation 2008; 117 (7): 963-74.
6. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): Te Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Toracic Surgery (EACTS). Eur Heart J 2012; 33 (19): 2451-96.
7. Alfieri O, Maisano F, De Bonis M, et al. Te double-orifice technique in mitral valve repair: a simple solution for complex problems. J Torac Cardiovasc Surg 2001; 122 (4): 674-81.
8. Maisano F, Caldarola A, Blasio A, De Bonis M, La Canna G, Alfieri O. Midterm results of edge-to-edge mitral valve repair without annuloplasty. J Torac Cardiovasc Surg 2003; 126 (6): 1987-97.
9. Feldman T, Whitlow PL, Wasserman HS, et al. Significant reduction in mitral regurgitation twelve months following percutaneous mitral valve repair: initial experience with MitraClip device. Paper presented at the American College of Cardiology 56th Annual Scientific Session, 24-27 March 2007, New Orleans, LA.
10. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol 2005; 46: 2134-40.
11. Feldman T, Foster E, Glower DD, et al; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364 (15): 1395-406. Epub 2011 Apr 4. Erratum in: N Engl J Med 2011; 365 (2): 189.
12. Whitlow PL, Feldman T, Pedersen WR, et al. EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012; 59 (2): 130-9.
13. Herrmann HC, Gertz ZM, Silvestry FE, et al. Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol 2012; 59 (14): 1312-19.
14. Schillinger W. Hot line II: Late breaking trials on interventions. ACCESS-EUROPE Phase I. A post market study of the mitraclip system for the treatment of significant mitral regurgitation in Europe: analysis of outcomes at one year. Presented at the European Society of Cardiology Congress, August 2012, Munich.
15. Franzen O, van der Heyden J, Baldus S, et al. MitraClip ® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011; 13 (5): 569-76.
16. Silberman S, Oren A, Klutstein MW, et al. Does mitral valve intervention have an impact on late survival in ischemic cardiomyopathy? IMAJ 2006; 8 (1): 17-20.